Home » Topics » Medical technology

Medical technology
RSS

MediGene Acquiring NeuroVir; Cardiogene Buys Intercardia

Nov. 10, 2000

Lynx Gains Eastern Foothold Through Takara License Deal

Nov. 10, 2000

Targeted Genetics Getting Up To $80M In Hemophilia Deal With GI

Nov. 10, 2000

Other News To Note

Nov. 10, 2000

European Patent Disclosures

Nov. 10, 2000

Targeted Genetics Forms Spin-Off Company For Cell Therapy Assets

Nov. 9, 2000

Corvas Raises $115M Publicly To Advance Multiple Programs

Nov. 9, 2000

Corrections

Nov. 9, 2000

Other News To Note

Nov. 9, 2000

NeoRx's Phase III STR Studies Suspended Due To Side Effect

Nov. 9, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...